NT_1170x120_1-11-18

WBA

WBA appoints Gourlay, Barra to drive operations

WBA appoints Gourlay, Barra to drive operations

DEERFIELD, Ill. — Alex Gourlay and Ornella Barra have been named co-chief operating officers of Walgreens Boots Alliance Inc. (WBA). Gourlay had been president of Walgreens, and Barra president and chief executive of global wholesale and international retail. Both had also been executive vice presidents of WBA. In his new role, Gourlay will oversee Walgreens

Analysis: Naming of co-COOs right step for WBA

Analysis: Naming of co-COOs right step for WBA

The appointment of Alex Gourlay and Ornella Barra as co-chief operating officers of Walgreens Boots Alliance signals the start of a new stage in the process of forging the two companies that came together to form WBA at the close of 2014 into a new corporate culture. The two executives, whose talent, experience and leadership

WBA names Gourlay, Barra co-COOs

WBA names Gourlay, Barra co-COOs

DEERFIELD, Ill. — Top Walgreens Boots Alliance (WBA) executives Alex Gourlay and Ornella Barra have been appointed as co-chief operating officers as part of a realignment of the company’s senior management team. WBA said Thursday that the naming of Gourlay and Barra as co-COOs will help streamline the management of its global operations, which have

Activist investor Rosenstein exits WBA board

Activist investor Rosenstein exits WBA board

DEERFIELD, Ill. — Activist investor Barry Rosenstein, managing partner of hedge fund JANA Partners LLC, has stepped down from the Walgreens Boots Alliance (WBA) Inc. board after reducing his investment in the company. WBA said late Friday that Rosenstein, who has been a director since September 2014, was slated to end his service on the

AmerisourceBergen, WBA extend relationship

AmerisourceBergen, WBA extend relationship

VALLEY FORGE, Pa. — AmerisourceBergen Corp. has extended its strategic partnership with Walgreens Boots Alliance (WBA) Inc. for another three years. AmerisourceBergen said Thursday that its drug distribution contract with WBA and relationship with Walgreens Boots Alliance Development (WBAD) have been lengthened to 2026. AmerisourceBergen and then-merger partners Walgreen Co. and Alliance Boots had announced

Walgreens Boots Alliance weighs options in Australia

Walgreens Boots Alliance weighs options in Australia

SYDNEY, Australia — Almost 100 years ago Australian pharmacists banded together to stop Boots the Chemist entering their market ­by setting up the Pharmacy Guild of Australia and successfully lobbying governments to enact laws restricting pharmacy location and ownership. Walgreens Boots Alliance Inc. (WBA) can expect a similarly frosty reception when it tries once again

Sales rise in 2Q at Walgreens Boots Alliance

Sales rise in 2Q at Walgreens Boots Alliance

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) reported double-digit revenue growth for its fiscal 2016 second quarter, with adjusted earnings per share topping Wall Street’s consensus forecast. WBA said Tuesday that second-quarter sales climbed 13.6% to $30.18 billion from $26.57 billion a year earlier. The gain stemmed largely from the full consolidation of Alliance Boots

The growing reach of Walgreens Boots Alliance

The growing reach of Walgreens Boots Alliance

The presence of Walgreens Boots Alliance (WBA) across the pharmacy care sector continues to broaden and deepen. Over two days earlier this month, WBA unveiled an integrated pharmacy offering with PBM OptumRx and then announced that it’s boosting its equity stake in drug distributor AmerisourceBergen. The highlight of the offering with OptumRx is that members

WBA increases its stake in AmerisourceBergen

WBA increases its stake in AmerisourceBergen

DEERFIELD, Ill. — As part of a long-term partnership announced three years ago, Walgreens Boots Alliance (WBA) is enlarging its equity stake in AmerisourceBergen. WBA said Friday that it has exercised warrants to buy more than 22,696,912 shares of AmerisourceBergen common stock for about $1.17 billion. The transaction was funded with cash on hand, and

Pessina: U.S. market WBA’s ‘greatest opportunity’

Pessina: U.S. market WBA’s ‘greatest opportunity’

NEW YORK — Walgreens Boots Alliance’s deal to acquire Rite Aid and partnership with Valeant Pharmaceuticals will build on WBA’s strong start in its first full year as a unified company, executive vice chairman and CEO Stefano Pessina said here at the annual shareholders meeting. “I am happy to say that we are on track

WBA starts off fiscal 2016 on strong note

WBA starts off fiscal 2016 on strong note

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) topped Wall Street’s earnings projections for its fiscal 2016 first quarter. WBA said Thursday that for the first quarter ended Nov. 30, 2015, adjusted net earnings attributable to Walgreens Boots Alliance were $1.13 billion, or $1.03 per diluted share, compared with $749 million, or 78 cents per diluted

WBA makes financing move for Rite Aid acquisition

WBA makes financing move for Rite Aid acquisition

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) Inc. has completed $12.8 billion in term loan facilities as part of the financing for its $17.2 billion deal to acquire Rite Aid Corp. WBA said Monday that the transactions include the placement of $5 billion of term loan facilities — split between two tranches of $2.5 billion

What it will take to get the WBA-Rite Aid deal done

What it will take to get the WBA-Rite Aid deal done

DEERFIELD, Ill. — Estimates vary widely on the number of stores Walgreens Boots Alliance Inc. (WBA) will divest as part of its $17.2 billion acquisition of Rite Aid Corp. In a filing with the Securities and Exchange Commission, WBA said the deal allows for up to 1,000 outlets to be closed or sold “if required